Table 2 Clinical and immunological profile of study participants at University of Gondar Teaching Hospital, North West Ethiopia, 2011
Variables | Pulmonary tuberculosis | Total | ||
|---|---|---|---|---|
Yes (TB-HIV) | No (HIV alone) | |||
WHO clinical stage (n = 72) | Stage III | 21 (34.4%) | 40(65.6%) | 61 (84.7%) |
Stage IV | 9 (81.8%) | 2 (18.2%) | 11 (15.3%) | |
Smear positive | Yes | 11 (100%) | 0 (0%) | 11 (2.7%) |
No | 19 (4.9%) | 370 (95.1%) | 389 (97.3%) | |
Chest radiography | Suggestive | 27 (100%) | 0 (0%) | 27 (6.7%) |
Not Suggestive | 3 (0.8%) | 370 (99.2%) | 373 (93.3%) | |
Constitutional symptoms (cough, fever, night sweat weight loss) | Yes | 28 (22.6%) | 96 (77.4%) | 124 (31%) |
No | 2 (0.7%) | 274 (99.3%) | 276 (69%) | |
CD4+ Lymphocyte count | <200Cells/mm3 | 16 (11.3%) | 126 (88.7%) | 142 (35.5%) |
200-349Cells/mm3 | 8 (5.6%) | 135 (94.4%) | 143 (35.8%) | |
≥350 Cells/mm3 | 6 (5.2%) | 109 (94.8%) | 115 (28.7%) | |